Daily analysis of Indian market events grounded in real corporate filings. Every claim is backed by what companies actually said in their annual reports and quarterly results.
The US Supreme Court ruling resetting tariffs to 15% gives Indian textile and pharma exporters a reprieve. We dig into filings to find who benefits most.
With Brent crude above $100 amid the Iran conflict, we dig into corporate filings to find which Indian companies face margin pressure from surging oil — and which upstream and energy names stand to gain.
The US has launched a Section 301 trade investigation targeting India. We dug into filings of pharma, auto component, and aluminium exporters to find who is most exposed.
With crude oil nearing $100/bbl amid the Strait of Hormuz crisis, we dig into company filings to identify the Indian stocks most exposed — and the unexpected beneficiaries.
IMD forecasts above-normal heatwave days. While markets crashed on oil fears, AC and cooling stocks rallied up to 6%. Here are 5 companies positioned to profit.
Karnataka shifted to ABV-based excise duty and deregulated liquor pricing. Beer gets cheaper vs spirits. Here is why United Breweries is the biggest winner.
The India-US trade deal gave generic pharma zero-duty access to America. Here are 6 companies whose FDA pipelines position them to capture this windfall.
Brent crude surged past $94 on US-Iran tensions. Here are 5 NSE stocks whose own filings reveal exactly how exposed they are to oil price shocks.